$6.92
-0.05 (-0.72%)
Open$6.90
Previous Close$6.97
Day High$6.92
Day Low$6.55
52W High$80.10
52W Low$2.98
Volume—
Avg Volume47.2K
Market Cap4.25M
P/E Ratio—
EPS$-461.25
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 12.09M | 14.07M | 1.35M |
| Net Income | -171,958,772 | -180,145,378 | 424.2K |
| Profit Margin | -1,422.8% | -1,351.6% | 31.3% |
| EBITDA | -114,930,962 | -127,091,623 | 830.6K |
| Free Cash Flow | — | — | 355.4K |
| Rev Growth | -14.1% | -14.1% | -3.8% |
| Debt/Equity | 0.08 | 0.08 | 1.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |